Content about Stimulants

November 30, 2010

A generic version of a drug indicated to treat attention deficit hyperactivity disorder has hit a roadblock.

November 14, 2010

The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use...

October 24, 2010

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

October 7, 2010

Clinical trial data indicating an increased risk of heart attack and stroke has led to...

September 30, 2010

Mylan has launched a generic version of a common antidepressant, the company said Friday....

August 22, 2010

The industry-supported Combat Meth-amphetamine Enhancement Act, H.R. 2923, passed muster at the House Committee on...

July 20, 2010

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....

July 20, 2010

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

July 8, 2010

The Food and Drug Administration on Thursday warned that Que She, marketed as an herbal...

July 6, 2010

The Food and Drug Administration has approved a drug made by Shire for treating attention...

May 16, 2010

Electronic tracking or prescription-only? That’s the question that vexed Congressional leaders last month as they...

May 3, 2010

The Food and Drug Administration has approved Mylan’s generic version of a smoking-cessation drug, Mylan...

March 29, 2010

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

March 8, 2010

Missouri has selected the National Precursor Log Exchange to serve as its statewide, real-time electronic...

March 3, 2010

The U.S. District Court for the District of Columbia has upheld a decision by the...

February 20, 2010

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...

January 21, 2010

Four Mississippi legislators earlier this month added the Magnolia State as one of those states...

January 10, 2010

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010

Watson has filed an abbreviated new drug application for the generic version of a sleep...

November 19, 2009

In a nutshell, this program gives any legislative body — state or local — debating...

October 18, 2009

There is a big danger here, and it’s a danger that has less to do...

July 19, 2009

In the short term, it means pharmacists operating out of one of the 12 or...

February 28, 2007

The most significant event that occurred during a soft 2006-2007 cough-and-cold season was the shift of the decongestant pseudoephedrine behind the counter in all 50 states. To be sure, some states still require more strict regulations on the sale of PSE, but at least now PSE is behind the counter in a legislative effort to thwart homegrown methamphetamine makers.

© 2014 Drug Store News. All Rights Reserved.